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One Small Step for Interoperability, One Giant Leap for Patients’ Rights 
Emma Lombard* 
I. Introduction 
In the digital age, the rise of technology means many things to many people.  For lawyers, 
it means that legal research can be done entirely online, without ever entering a library or picking 
up a Reporter.1  For doctors, it means that they can make house calls, without ever leaving their 
office.2  The list goes on.  Most importantly, for many people, it means that they can communicate 
with just about anyone, anywhere in the world, instantaneously.  Along with the plethora of 
benefits that advances in technology bring, there is the accompanying risk of misuse.  Because 
“the amount of data created and collected is exponentially rising,” the average data breach now 
affects more people than ever before.3  While data breaches have occurred for as long as 
individuals and companies have maintained records and stored private information, they have 
increased significantly in number and magnitude as more companies and individuals rely on 
computers for communication, record-keeping, and administrative uses.4  A data breach is best 
defined as “an incident in which sensitive, protected, or confidential data has potentially been 
viewed, stolen, or used by an individual unauthorized to do so.”5  Breaches in the administration 
of healthcare have become increasingly prevalent—the origins of which are complex to trace. 
 
*J.D. Candidate, 2021, Seton Hall University School of Law; B.A., 2017, University of California Santa Barbara.  
1 Rachel Buchanan, The Role of Technology in the Future of Legal Professions, OXFORD UNIVERSITY RESEARCH 
COLLECTION: LAW AND TECHNOLOGY (Feb. 27, 2017), https://www.law.ox.ac.uk/research-and-subject-
groups/research-collection-law-and-technology/blog/2017/02/role-technology. 
2 Mei Wa Kwong, Telehealth and Public Programs - Evolution of Telehealth Policy in Medicare and Medicaid, 15 J. 
HEALTH & BIOMED. L. 7, 8 (2019). 
3 Danielle Abril, Data Breaches Declined Last Year. But Here’s Why You Should Be More Worried Than Ever, 
FORTUNE (Jan. 29, 2019), https://fortune.com/2019/01/29/data-breaches-decline-2018-consumer-data-risk-rises/.  
4 Juliana De Groot, The History of Data Breaches, DIGITAL GUARDIAN: DATA INSIDER (Oct. 24, 2019), 
https://digitalguardian.com/blog/history-data-breaches. 
5 Id. (including among the most common types of breached data: “payment card information (PCI), personal health 
information (PHI), personally identifiable information (PII), trade secrets, or intellectual property.”). 
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Healthcare data breaches, in particular, are on the rise.6  Over the past seven years, the 
annual number of health data breaches has risen by seventy percent—with seventy-five percent of 
those breached, lost, or stolen records resulting from “hacking or IT incident.”7  This “nebulous 
category created by the government” does not distinguish between malicious data theft (such as 
phishing attempts and ransomware) and accidental loss (such as sending to an unintended 
recipient).8  Unlike other data breaches, healthcare data breaches involve what is known as 
“protected health information” (PHI).9  PHI is any personally “identifiable health information that 
is used, maintained, stored, or transmitted by . . . [a] healthcare provider, health plan or insurer, or 
a healthcare clearinghouse – or a business associate” of one of those entities.10  It includes past, 
current, and future health information related to the administration of care or payment for care, 
regardless of the form in which it is kept.11  Importantly, this includes both physical and electronic 
records, as well as spoken information.12  “Essentially all health information is considered PHI 
when it includes individual identifiers,” such as patient names, Social Security numbers, driver’s 
license numbers, birth dates, telephone numbers, or e-mail addresses.13  
In recent years, more healthcare providers have begun implementing Electronic Health 
Records (EHR) into their practices—and in doing so, patients have received many benefits.14  By 
making health records available to patients in a digital format, patients can more easily access the 
 
6 Helen R. Pfister and Randi Seigel, MASSIVE DATA BREACH UNDERSCORES IMPORTANCE OF BUSINESS ASSOCIATE 
SECURITY, 5–7 Pratt’s Privacy and Cybersecurity Law Report 05 (2019). 
7 Id.  
8 Michela Tindera, Government Data Says Millions of Health Records Are Breached Every Year, FORBES: MONEY & 
POLITICS (Sept. 25, 2018, 11:30 AM), https://www.forbes.com/sites/michelatindera/2018/09/25/government-data-
says-millions-of-health-records-are-breached-every-year/#51a8b93416e6. 
9 HIPAA Journal, https://www.hipaajournal.com/considered-phi-hipaa/ (last visited Oct. 10, 2019).  
10 Id. 
11 Id.  
12 Id.  
13 Id. While there are mechanisms by which the access of electronic records can be recorded, it is worth noting that 
other such breaches are much more difficult to track.  
14 Sara Heath, How Patient Health Data Access Drives Patient Engagement, PATIENT ENGAGEMENT HIT (June 3, 
2016), https://patientengagementhit.com/features/how-patient-health-data-access-drives-patient-engagement. 
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information, the information can be updated more quickly, and patients can be in charge of taking 
the necessary steps to safeguard their own health.15  Not only can they track their visits, but they 
can view test results and cross-reference the information uploaded by their doctors.  Studies have 
similarly shown that when patients are engaged in other ways, such as being able to schedule and 
confirm appointments electronically or through text message, they are more responsive and less 
likely to no-show to an appointment.16  In response to these kinds of integration efforts by 
providers, there has been a push to develop other methods of health information technology.17  
Online portals and other new technologies have proven increasingly effective at getting patients 
more involved in their care, leading to better outcomes.18  While patients typically wait to hear 
from doctors until they are able to call them to deliver test results or until they have an appointment 
to see the doctor next, this method of making data available online allows patients to access their 
health information in real-time—rather than being at the mercy of a doctor’s hectic schedule. 
Despite the obvious ways in which technology has advanced and become integrated into 
the administration of healthcare, the legal safeguards for cybersecurity matters have not progressed 
as rapidly.  The first federal law created to address mounting concerns was the Health Insurance 
Portability and Accountability Act of 1996 (HIPAA).19  HIPAA is commonly known as the Privacy 
Rule, which requires, among other things, that those in possession of patient data take measures to 
 
15 HEALTHIT.GOV https://www.healthit.gov/faq/what-are-advantages-electronic-health-records (last updated May 16, 
2019).  
16 Sara Heath, How Text Message Communication Improves Patient Outreach, (Oct. 15, 2018), 
https://patientengagementhit.com/news/how-text-message-communication-improves-patient-outreach (this is 
particularly as it pertains to text-message reminders for patients and more modern forms of technology rather than 
calling patients). 
17 Sara Heath, How Patient-Centered Care Is Shaping Provider Health IT Strategy, (Sept. 9, 2019), 
https://patientengagementhit.com/news/how-patient-centered-care-is-shaping-provider-health-it-strategy. 
18 Sara Heath, 6 Patient Engagement Technologies that Improve Clinic Operations, (Aug. 22, 2019), 
https://patientengagementhit.com/news/6-patient-engagement-technologies-that-improve-clinic-operations. 
19 Johnathan D. Bick, Cybersecurity: A Combination of Legal, Business and Technical Measures, NEW JERSEY L. J. 
(Oct. 28, 2019). 
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protect it from accidental exposure or malicious theft.20  If a patient’s information is compromised 
or exposed during a data breach, that individual has certain rights and remedies.21  While there is 
no private right of action under HIPAA, which would allow an individual patient to sue an entity, 
a patient may report the violation to the Secretary of Health and Human Services, who can then 
bring an enforcement action.22  HIPAA does not preempt state laws that give rise to a private cause 
of action, and many courts hold that failure to comply with HIPAA serves as evidence that a 
physician failed to act reasonably, thus deviating from the standard of care.23  In addition, a covered 
entity that is aware of a breach has a duty to inform patients that the security of their health 
information has been compromised.24 
Following this trend toward electronically stored information and in furtherance of the goal 
to improve patient access and engagement, the Center for Medicare and Medicaid Services (CMS) 
proposed and recently passed an interoperability rule.25  Interoperability has many technical 
definitions but put most simply, it “is the ability of two or more systems to exchange information 
and to interpret and use that information.”26  The purpose of the rule is “to move the health care 
ecosystem in the direction of interoperability,” and to signal CMS’ commitment to improving 
access to, and the quality of, healthcare information.27  The Final Rule seeks to prioritize the 
availability of the information necessary for patients to make informed health care decisions.  
Ideally, the rule does so without increasing the burden on health care providers and payers.28  In 
 
20 Id.  
21 Id.  
22 42 U.S.C.S. § 300gg-22 (LexisNexis, Lexis Advance through Public Law 116–65, approved October 9, 2019). 
23 Id.  
24 42 U.S.C.S. § 17932 (LexisNexis, Lexis Advance through Public Law 116–65, approved October 9, 2019). 
25 84 Fed. Reg. 7610, (March 4, 2019) (https://www.govinfo.gov/content/pkg/FR-2019-03-04/pdf/2019-02200.pdf). 
26 HIMSS, https://www.himss.org/library/interoperability-standards/what-is-interoperability (last visited Oct. 12, 
2019).  
27 Id. This includes both medical records from providers and claim information from insurers. 
28 Id.  
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application, the interoperability rule purports to give patients access to their health information by 
requiring providers and insurers to compile that information into one EHR, made available through 
an application programming interface (API).29  An API is a system by which “third party software 
applications connect to make the data available to patients.”30  The “open API”31 would include 
both medical information (such as test results and diagnoses) as well as healthcare plan information 
(such as a provider directory and claims data).32  While all of this information is certainly available 
to patients through various platforms, the task of collecting this data “can be burdensome and 
frustrating to the consumer.”33 
Although the final rule’s framework under CMS’ rule for increasing patient access to EHRs 
serves a worthwhile and meaningful purpose, its implementation is more complicated, if not 
entirely undermined by stringent state privacy laws.  This Comment proposes that in order for this 
interoperability rule to succeed at increasing patient access to health data without putting patients 
at an increased risk of data breaches, Congress should amend the definition of “covered entities” 
to include the third-party applications that will collect and maintain the patient health data.  
Additionally, in the absence of the implementation of a Federal Privacy statute, Congress should 
create a private right of action under HIPAA to ensure that patients who do suffer adverse effects 
from a data breach are not without recourse.  Section II of this Comment addresses past efforts to 
promote interoperability and the ways in which such efforts have progressed toward, but ultimately 
fell short of, the ultimate goal of interoperability.  Section III of this Comment discusses the current 
efforts and strategy on which the rule relies.  Section IV addresses the benefits of interoperability, 
 
29 84 Fed. Reg. 7610, 7612, 7627. 
30 84 Fed. Reg.  7610, 7612. 
31 84 Fed. Reg.  7617. 
32 84 Fed. Reg.  7619.  
33 Id.  
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while Section V discusses the barriers (both potential and actual) impeding the rule’s 
implementation.  Section VI adds other considerations which may complicate compliance with the 
rule, and Section VII concludes with proposed solutions to the problems that will arise.  This 
Comment will not address the cybersecurity issues posed by implementation but will instead focus 
on the practical problems posed by attempts at compliance with both state laws and the CMS rule 
given that no federal privacy law exists.   Rather than advocating for a federal privacy law, the 
proposed solutions focus on ways to amend HIPAA.       
II. Past Efforts to Promote Interoperability 
This rule is not the first effort by CMS and Congress to achieve interoperability, but it is 
the most recent effort to achieve it on a widespread scale. While it is certainly a revolutionary 
measure, this newfound emphasis is also a long time coming.  CMS and Congress have worked 
toward a rule such as this by passing acts that play a key role in incentivizing providers to integrate 
technology into their practices. 
In 2009, Congress implemented the Health Information Technology for Economic and 
Clinical Health Act (HITECH),34 which provided an opportunity to move interoperability forward 
by “authorizing CMS to make incentive payments to eligible professionals, eligible hospitals and 
critical access hospitals, and Medicare Advantage (MA) organizations to promote the adoption 
and meaningful use of certified electronic health record technology (CEHRT).”35  It also codified 
the Office of the National Coordinator for Health Information Technology (ONC).36 This 
codification is significant because it bestowed regulatory authority upon the newly created agency 
and allowed it to enforce these measures in a way that had not previously occurred.  This was a 
 
34 42 U.S.C.S. § 17932 (LexisNexis, Lexis Advance through Public Law 116–65, approved October 9, 2019). 
35 84 Fed. Reg. 7610, 7612. 
36 42 U.S.C.S. § 17932 (LexisNexis, Lexis Advance through Public Law 116–65, approved October 9, 2019). 
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crucial move toward the integration of interoperability because it allowed CMS to incentivize 
providers to join in the efforts while offering its own guidance and standards.  It involved three 
stages of implementation, allowing providers to integrate technology at a gradual pace. Stage 1 
created a foundation for the EHR Incentive Programs by enacting requirements for capturing 
clinical data electronically, which included the requirement to provide patients with electronic 
copies of health information.37  Stage 2 focused on advancing clinical processes and “ensuring that 
the meaningful use of EHRs supported the aims and priorities of the National Quality Strategy.”38 
Stage 2 criteria encouraged the use of CEHRT for continuous quality improvement at the point of 
care and the exchange of information in the most structured format possible.”39  “Stage 3 focuses 
on using CEHRT to improve health outcomes.”40  
The federal government has spent over $35 billion under these EHR Incentive Programs, 
and while seventy-eight percent of physicians41 and ninety-eight percent of hospitals42 now use a 
certified EHR system, there has been very limited progress toward the implementation of an API, 
or a method to share system-wide data.43  Because these incentivization programs were only 
partially successful, more changes were necessary.  In 2010, ONC established a set of initial 
standards for the temporary certification program.44  In 2011, the ONC changed those standards to 
create a Permanent Certification Program, showing the continued commitment of the government 
 
37 84 Fed. Reg.  7610, 7612. 
38 Id. 
39 Id.  
40 Id. 
41 ONC, HEALTH IT DASHBOARD, Office-Based Physician Health IT Adoption: State Rates of Physician EHR 
Adoption, Health Information Exchange & Interoperability, and Patient Engagement,  
https://dashboard.healthit.gov/apps/physician-health-it-adoption.php (last visited November 2, 2019).  
42 ONC, HEALTH IT DASHBOARD, Non-Federal Acute Care Hospital Health IT Adoption and Use: State Rates of Non-
Federal Acute Care Hospital EHR Adoption, Health Information Exchange and Interoperability, and Patient 
Engagement,  https://dashboard.healthit.gov/apps/hospital-health-it-adoption.php (last visited November 2, 2019).  
43 84 Fed. Reg. 7610, 7612. 
44 Id.  
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to prioritize interoperability in a meaningful and practical way.45  Given the amount of money that 
the federal government has spent promoting interoperability and giving providers an opportunity 
to pursue it themselves, it makes sense that the rule codifies and mandates these practices. 
Congress enacted another important piece of legislature, the Medicare Access and CHIP 
Reauthorization Act (MACRA),46 in April of 2015.47  The stated aim of MACRA was to “achieve 
widespread exchange of health information through interoperable CEHRT nationwide.”48  The Act 
defines interoperability as “the ability of two or more health information systems or components 
to exchange clinical and other information and to use the information that has been exchanged 
using common standards as to provide access to longitudinal information to facilitate coordinated 
care and improved patient outcomes.”49  Congress declared, in MACRA, that it was a national 
objective to achieve widespread exchange of health information through interoperable certified 
EHR technology nationwide by December 31, 2018.50  Based on the response to MACRA, ONC 
identified two metrics for measuring interoperability.51  The first measure is the proportion of 
health care providers who electronically engage in “sending, receiving, finding, and integrating 
information received from outside sources” as opposed to those which are not.52  The second 
measure is “the proportion of health care providers who report using the information they 
electronically receive from outside providers and sources for clinical decision-making.”53  ONC 
 
45 45 CFR part 170. 
46 114 P.L. 10, 129 Stat. 87, 2015 Enacted H.R. 2, 114 Enacted H.R. 2, 114 P.L. 10, 129 Stat. 87, 2015 Enacted H.R. 
2, 114 Enacted H.R. 2. (CHIP refers to Children’s Insurance Plan).  
47 Id.  
48 84 Fed. Reg. 7610, 7613. 
49 Id.  
50 Id. 
51 Id.  
52 ONC, HEALTHIT.GOV 
https://www.healthit.gov/sites/default/files/fulfilling_section_106b1c_of_the_medicare_access_and_chip_reauthoriz
ation_act_of_2015_06.30.16.pdf (last visited Oct. 25, 2019) (The former which the ONC considers “the core domains 
of interoperable exchange of health information.”) 
53 Id. 
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stated in 2018 update to Congress that it would continue to measure and evaluate performance 
according to these measures, keeping a keen eye on policy changes being implemented under the 
21st Century Cures Act.54 
III. Current Efforts 
In recent years, there has been a great deal of legislation that has further shaped the health 
privacy landscape for payors, providers, and patients.  In April 2018, EHR Incentive Programs and 
the MIPS Advancing Care Information Performance category became “Promoting Interoperability 
Programs” as “just one part of the CMS strategic shift in focus to advancing health IT and 
interoperability.”55  21st Century Cures Act56 Section 4003 defines interoperability with respect to 
health IT as “technology that enables the secure exchange of electronic health information from, 
other health IT without special effort on the part of the user.”57  It also provides for “complete 
access, exchange, and use of all electronically accessible health information for authorized use 
under applicable state or federal law and does not constitute information blocking as defined in 
section 3022(a).”58  Information blocking refers to any practice that  a provider knows or should 
know “is likely to interfere with, prevent, or materially discourage access, exchange, or use of 
electronic health information.”59  The two practices can be in tension, but this bill promotes and 
funds the acceleration of research into methods for prevention and cures for serious illnesses—for 
 
54 HHS & ONC, 2018 Report to Congress, https://www.healthit.gov/sites/default/files/page/2018-12/2018-HITECH-
report-to-congress.pdf (last visited Nov. 1, 2019).  
55 84 Fed. Reg. 7610, 7613. 
56 21st Century Cures Act, Pub. L. No. 114-255,130 Stat. 1033 (codified at 42 U.S.C. §§300jj(11) –(14) (Supp. V 
2018)). 
57 42 U.S.C.S. § 300jj (9) (LexisNexis, Lexis Advance through Public Law 116–56, approved August 23, 2019). 
58 42 U.S.C.S. § 300jj (9) (LexisNexis, Lexis Advance through Public Law 116–56, approved August 23, 2019). 
59 42 U.S.C.S. § 300jj-52(a)(1) (LexisNexis, Lexis Advance through Public Law 116–56, approved August 23, 2019). 
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which it is aptly named.60  While the bill is largely about funding research, it contains provisions 
about information blocking and interoperability.61 
Since its implementation, the ONC has introduced another proposed rule that outlines 
seven main exceptions—situations in which activities that would otherwise constitute information 
blocking are exempt from that characterization.62  The full effect of these exceptions has not yet 
been realized, as they are part of a rule that will go into effect in 2020—the same time as the 
interoperability rule.63  It is somewhat difficult to recognize the trend toward creating more 
leniency in the enforcement of the act.  In May 2019, the Health Innovation Alliance called on 
ONC to “go back to the drawing board” and rework the proposal.64  The group said the seven 
exceptions “contain too many loopholes which would result in extensive litigation before there can 
be meaningful enforcement of the 21st Century Cures Act prohibition on information blocking.”65  
CMS has not, as of yet, provided more guidance on the proposal.  
The interoperability rule arguably works with the 21st Century Cures Act through 
requirements that prevent information blocking.66  Information blocking works both to protect 
patient data and to limit the liability of providers in charge of uploading that data.67  But the 
 
60 HIMSS, 21st Century Cures Act—A Summary, (Feb. 20, 2017), https://www.himss.org/news/21st-century-cures-
act-summary.  
61 Id.  
62 James A. Cannatti III et al., THE NATIONAL LAW REVIEW, (Feb. 14, 2019), 
https://www.natlawreview.com/article/onc-proposes-to-define-conduct-not-information-blocking-under-cures-act.  
Those seven exceptions are: (1) preventing physical harm to patients and others; (2) promoting privacy of EHI; (3) 
promoting security of EHI; (4) recovering costs reasonably incurred to provide access, exchange, or use of EHI;  (5) 
responding to infeasible requests to provide access, exchange, or use of EHI; (6) licensing interoperability elements; 
and (7) maintaining and improving performance of health information technology. 
63 Id. 
64 Providers Call For HIPAA Clarity On Proposed Info Blocking Exceptions, INSIDE HEALTH REFORM (June 12, 2019). 
65 Id.  
66 Lynsey Mitchel, Overview of Proposed Rule from the Centers for Medicare & Medicaid Services Regarding 





interoperability rule extends the requirement to make data available by focusing heavily on APIs, 
and simultaneously focusing on data privacy.68  CMS believes that because the APIs have 
standardized technology, are technically transparent, and are implemented in a pro-competitive 
manner, they will allow for meaningful and convenient access to electronic health records.69  If the 
API technologies are standardized, it will be easier for payors (insurers) to update the information 
and for patients to not only access the information but also to understand it.70 
To promote transparency, “CMS is proposing to require that API-documentation be 
publicly accessible – meaning any individual using commonly available technology to browse the 
internet could access the information without any preconditions or additional steps beyond 
downloading and using a third-party application.”71  The idea behind pro-competitive implication 
is that pro-competitive practices “promote the efficient access to, exchange of, and use of 
electronic health information to support a competitive marketplace that enhances consumer value 
and choice of direct-to-consumer technology, health coverage and care.”72 
Seemingly, CMS believes that by creating a need and a market for APIs, more APIs will 
be developed.  Within this competition to create them quickly and effectively, there will emerge 
better, lower-cost APIs.  This strategy may also address the current problem providers face because 
there is little compatibility between and among different formats of healthcare data.  This problem 
is due in large part to the fact that the EHR companies “have little incentive to make it easy to 
 
68 Id.   
69 Id.  
70 Id.  
71 Id. 
72 Lynsey Mitchel, Overview of Proposed Rule from the Centers for Medicare & Medicaid Services Regarding 




share data with providers who use their competitors’ software.”73  CMS distinguishes two types of 
interoperability that it intends to promote with the rule: technical interoperability and semantic 
interoperability.74  Technical interoperability refers to the capability of systems to “connect and 
exchange” data without alteration, and semantic interoperability refers to the capability of systems 
to “interpret and use” the data that has been exchanged.75  The goal is to achieve both of these 
objectives simultaneously.76 
Under the rule, the open API must include: “adjudicated claims (including cost); 
encounters with capitated providers; provider remittances; enrollee cost-sharing; clinical data, 
including laboratory results.”77  The API should also include other information patients need to 
easily access care, such as a provider directory so that patients can easily select a doctor within 
their network.78  There are practical limits to updating this information and while insurance 
providers face penalties for inaccuracies in the directories,79 providers themselves are under no 
penalty for being unresponsive to inquiries from patients.  It is unclear if the implantation of this 
data into APIs would remedy this problem, it should certainly be a goal.  This data must be updated 
“no later than one (1) business day after a claim is adjudicated or the encounter data is received by 
the plan” because the immediacy/timeliness of the updates is a crucial part of allowing providers 
to make determinations and to keep patients updated, as the rule intends to.80  Because one day is 
 
73 Heather Bell, CMS Announced 3 New Interoperability Initiatives. Here’s What You Need to Know, AMERICAN 
HEALTH LINE (Mar. 7, 2018). 
74 84 Fed. Reg. 7615. 
75 84 Fed. Reg. 7615. 
76 84 Fed. Reg. 7619. 
77Lynsey Mitchel, Overview of Proposed Rule from the Centers for Medicare & Medicaid Services Regarding 





80 Id.  
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not a long period of time, the practical limits of the requirements become relevant to the 
effectiveness of the overall stated purpose.81  This information can be used, in theory, to better 
aggregate a patient’s data and to prioritize research that will assist in detecting diseases earlier and 
more accurately.  
IV. Other Benefits 
When patients have access to all of the data in their medical records, they can take that data 
“with them from doctor to doctor, or to their other health care providers” more easily because they 
would already have access to it in a format that belongs to them.82  This would not only mean that 
patients can choose a doctor that is available to them and meets their needs, but this would also 
“give that provider secure access to their data, leading to greater competition and reducing costs.”83  
Immediate access to data lessens the burden on patients because if they wish to take their medical 
records to a new doctor, they do not have to wait for their provider to compile the records, print 
them, and then pick them up.  They also will not have to pay the cost of printing or compiling the 
records. 
The move toward interoperability will also assist in the healthcare industry’s shift to 
“value-based payments.”84  “Value-based payment” models focus on rewarding hospitals, 
physicians, and other providers “for delivering high-quality health care” by tying payment to 
value.85  As the name aptly suggests, payments are based on value: the monetary amount providers 
 
81 Jessica Kim Cohen, AMA, CHIME Call for Interim Info-Blocking Rule, MODERN HEALTHCARE (Sept. 23, 2019, 
1:01 PM), https://www.modernhealthcare.com/technology/ama-chime-call-interim-info-blocking-rule (calling for 
supplemental rulemaking “to address a slew of industry concerns”). 
82 Heather Bell, CMS Announced 3 New Interoperability Initiatives. Here’s What You Need to Know, AMERICAN 
HEALTH LINE (Mar. 7, 2018).  
83 Id.  
84 Id.  
85 Sylvia M. Burwell, Setting Value-Based Payment Goals – HHS Efforts to Improve U.S. Health Care, NEW ENGLAND 
JOURNAL OF MEDICINE 372;10, PAGE 897 (Mar. 5, 2015) (available at 
https://pdfs.semanticscholar.org/0b48/6979fc7c7a9908db78ac99f9a070f62a455e.pdf). 
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receive is directly tied to the quality of the healthcare they provide to patients.86  The “value” is 
measured by certain benchmarks, and in some “bundled care” arrangements, providers are 
encouraged to work as a team with a network of other providers to deliver the care efficiently 
together.87  If, for instance, a patient needs to attend physical therapy prior to or after undergoing 
a surgical operation, a value-based payment model is one in which the surgeon and physical 
therapist work together to coordinate the patient’s care and to ensure the patient makes a full 
recovery, within a specified time frame, in order to receive a higher level of payment.  Essentially, 
the providers receive a bonus payment for ensuring the patient receives care quickly, but without 
sacrificing the quality of the care they receive.  The incentive works to lower healthcare costs 
overall by preventing unnecessary visits to multiple providers and to ensure better patient care 
through coordination between and among providers.88  As more insurers are beginning to 
incorporate value-based payment models and other alternative payment models, there is a need to 
better facilitate the exchange of patient data to meet the benchmarks outlined in the payment 
structures.89  Interoperability would assist this goal by allowing all providers involved in the 
administration of care to access and update patient information, and would similarly allow the 
insurer or payer to monitor the patient’s progress on an active basis.90   
 
86 Id.  
87 Id. The benchmarks are often metrics related to how quickly the patient recovers, how full of a recovery they make, 
and so on.  The benchmarks ensure that doctors do not compromise the quality of care they provide in order to achieve 
the bonus payment. 
88 Id.  
89 Chelsea Cirruzzo, CMS Releases New Model Request for Applications Amid Push Towards APMs, INSIDE HEALTH 
REFORM (Oct. 30, 2019).  
90 Sylvia M. Burwell, Setting Value-Based Payment Goals – HHS Efforts to Improve U.S. Health Care, The New 
England Journal of Medicine, N. Engl. J. Med 372;10. March 5, 2015. (available at 
https://pdfs.semanticscholar.org/0b48/6979fc7c7a9908db78ac99f9a070f62a455e.pdf). 
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Most importantly, the API platform can be utilized to prioritize certain findings within a 
patient’s medical records.91  If providers work with software developers to prioritize data based on 
certain symptoms, the patient’s age, or their medical history, this could ease the burden on 
providers to look back at the patient’s entire medical history before making a diagnosis and 
recommendation.92  For example, “a vendor can develop software that prioritizes a patient’s most 
recent hospital visit over a negative colonoscopy.”93  This would revolutionize the way that doctors 
provide care and utilize their medical judgment when diagnosing patients.  By employing an API 
capable of analyzing the data and self-selecting important information, doctors could, in theory, 
view a list of different diagnoses proposed by the software and then decide the best course of 
treatment.  While in many cases this may automatically present a solution, doctors could also use 
the information gleaned by the API to employ additional tests to confirm the diagnosis.   
The API would work by combining a patient’s symptoms and her test results or vital signs 
to categorize possible medical diagnoses.  By automating this crucial function, providers can more 
accurately treat patients and screen for more potential diseases by having all of the information in 
one place.  Instead of relying on a patient’s inevitably faulty memory, providers would be able to 
search a patient’s complete medical record for other symptoms or potential complications and 
ascertain with better precision the proper diagnosis and course of treatment for the patient.  
Because the data would be automatically prioritized for the provider, this could lessen provider 
response time.  It could also allow for providers to “create high-risk alerts for certain patients,” 
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and run the data through the software to eliminate care options and select the best one for the 
patient, perhaps by also including the patient’s history into the care analysis.94   
The COVID-19 pandemic has brought pre-existing conditions to the forefront of our minds 
and the news cycle.  This emphasis on increasing awareness about which demographics are most 
at-risk to contract the coronavirus is a real-life example of how this tool could work to help identify 
diseases sooner and to proactively treat patients.  As the CDC gathers more information from 
patients who have contracted coronavirus, it can better identify which patients are at a heightened 
risk.  This seems elementary, given what we know now, but when the first cases of the virus were 
spreading, the lack of information greatly contributed to its transmission.  This example highlights 
how important it is—now more than ever—to use the power of data to help people stay healthy or 
to recover from illnesses.  
V. Perceived and Actual Barriers to Implementation 
There are difficulties associated with fully implementing interoperability and there is 
uncertainty among providers about their ability to comply with both the interoperability rule and 
HIPAA.  This can be dealt with simply by understanding what HIPAA is and what it is not.  HIPAA 
was passed to help protect and safeguard the security and confidentiality of a person's health 
information.95  One part of HIPAA, the Privacy Rule, aims to keep a patient’s medical information 
private and prevent unnecessary disclosures of his or her PHI.96  That certainly does not mean that 
a doctor can never talk to anyone about a patient’s health information—doctors can still disclose 
a patient’s PHI without his or her express written consent in many situations, especially if it is 
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related to treatment, payment, or health care operations.97 For example, if a patient has a heart 
attack, his doctor has to inform his insurance company in order to receive payment, but his credit 
card company does not have to be told about it.98  If that same patient fell behind in paying his 
medical bills, that fact can be reported to credit agencies (but they cannot identify which bills or 
for which procedures the patient has yet to pay).99  Under HIPAA, PHI is considered to be 
individually identifiable information relating to the past, present, or future health status of an 
individual that is created, collected, or transmitted, or maintained by a HIPAA-covered entity in 
relation to the provision of healthcare, payment for healthcare services, or use in healthcare 
operations (PHI healthcare business uses).100  This includes “diagnoses, treatment information, 
medical test results, and prescription information,” as well as “national identification numbers and 
demographic information such as birth dates, gender, ethnicity, and contact and emergency contact 
information.”101 This means that entities not covered by HIPAA are not required to safeguard PHI 
and are not subject to penalties for mishandling it.102  If all personal identifiers are stripped from 
health data, it ceases to be protected health information and the HIPAA Privacy Rule’s restrictions 
on uses and disclosures no longer apply.103  In the context of interoperability, however, all 
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To finance healthcare, administer benefits, and check benefit eligibility, a health insurer 
may, and always does, access medical records.104  Improper use or access of data, outside of this 
limited scope, would be considered a breach.105  It is a myth that a healthcare provider is required 
by law to provide all medical records to a patient when they exercise their right to request a copy 
of their records.106  This exception serves as an additional protection for patients—if a doctor 
believes a patient’s records will prove harmful (or if a doctor suspects a patient might inflict self-
harm after viewing the records) then a doctor may deny the patient access.107  Providers are not 
required to correct errors found in patient records—however, patients may request changes to their 
records.108  Patient access to medical records is therefore essential—without access, patients will 
be unable to identify mistakes or request corrections.  According to a 2016 study by Johns Hopkins, 
an estimated 250,000 patients die each year as a result of “diagnostic errors and medical 
mistakes.”109  Ross Kopel, a Health IT academic, estimates that nearly seventy percent of patient 
medical records contain mistakes.110  Many of these errors are “irrelevant to health outcomes,” 
such as listing that a patient twisted her ankle “on a Thursday, when it was in fact, Friday.”111   
Even when these mistakes are not acutely fatal, it is possible that many mistakes or 
instances when doctors accidentally overlook critical data for the patient’s care do prevent patients 
from being diagnosed at an early stage.  Particularly with cancer diagnoses, the importance of early 
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detection and prevention is the single most important factor to a patient’s chances of survival.  
Interoperability would serve to curb this problem by allowing patients to actively monitor their 
EHR and to prevent inaccuracies from impacting the care they receive.  While a patient may not 
remember what she told her physician during a yearly physical four years prior, she will ostensibly 
remember quite well what she told her doctor earlier in the day, the week, or the month.   
By enabling patients to take an active role in monitoring their own records, not only will it 
ensure better accuracy, but it will also create an additional mechanism by which fraudulent claims 
can be identified, thereby combating rising healthcare costs in the aggregate.112  In cases where 
providers may be inclined to alter medical records to reflect (and then bill for) services not actually 
rendered, the ability of patients to monitor their health records and claims data will function as a 
deterrent.  The lack of patient involvement in medical record maintenance can pose serious 
problems during the administration of their health benefits.  Even if a patient has coverage for a 
service, their health insurer may deny a portion of a claim or an entire claim simply because the 
information provided by the doctor (or the lack thereof) negates the needs for the insurer to pay 
for it.  This is only one of many examples of how mistakes in medical records can pose problems 
for patients.  Because patients trust their providers to upload the information correctly, they have 
little ability to check that the information is correct.  For example, a patient may have his or her 
information mistakenly placed in another person’s file, such as a sibling’s file, or another family 
member.  A provider could mistakenly update a patient’s information twice, to reflect a procedure 
they only had once and should have been covered for the first time, but their insurance may refuse 
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the second.  By allowing patients to actively check this information as it is uploaded, rather than 
after a problem arises with it, there will be fewer issues with which to deal. 
In addition to easing access for patients, the Final Rule purports to champion ease of access 
for providers.  In anticipating a problem that will arise through the initial implementation of the 
API, CMS has offered guidance on how to connect the many pieces of claim data and healthcare 
records that an individual patient will have (in the absence of the ability to implement a Universal 
Patient Identifier (UPI)).113  The use of a UPI would be similar to a license plate number or a 
driver’s license number, where each person has a unique combination of letters and numbers.114  
The main concern with UPIs is that they are easy to identify, once standardized, and lack the 
requisite security.115  If every hospital, doctor’s office, and healthcare insurance company suddenly 
organizes patient files simply by a string of letters and numbers, it may be easier to compromise.116  
Instead, CMS proposes the use of “patient-matching,” a process whereby demographic and other 
unique information is used to match the data to the patient.117   
Another potential barrier to complete implementation of interoperability relates to the 
Substance Abuse and Mental Health Services Administration (SAMSHA).118  As a federal agency 
established by Congress in 1992 within the U.S. Department of Health and Human Services that 
“leads the public health efforts to advance the behavioral health of the nation,”119 SAMSHA 
recently released a final rule, known as 42 CFR Part 2, which modernized the confidentiality 
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requirements for substance use disorder (SUD) patient records.120  “Previously, Part 2 applied to 
disclosures that ‘would identify a patient as an alcohol or drug abuser.”121  Now, Part 2 applies to 
SUDs, which are defined as “a cluster of cognitive, behavioral, and physiological symptoms 
indicating that the individual continues using the substance despite significant substance-related 
problems such as impaired, control, social impairment, risky use, and pharmacological tolerance 
and withdrawal.”122  This definition does not include tobacco or caffeine use.  In commentary, 
SAMHSA provides examples such as “alcohol, cannabis, hallucinogens, inhalants, opioids, 
sedatives, hypnotics, anxiolytics, and stimulants.”123  Under Part 2, a Part 2 Program must obtain 
written patient consent to disclose information related to SUD treatment.124  The consent must 
contain: “the patient’s name; the part 2 program permitted to make the disclosure; the amount and 
kind of SUD-related information to be disclosed; and the name of the individual or entity that is to 
receive that information.”125  While “tracking disclosures may prove to be burdensome to Part 2 
Programs,”126  this heightened level of privacy for patient information aligns with the sensitive 
nature of SUD treatment and should be afforded to all patients seeking SUD treatment that wants 
their information to remain private. The administrative burden is light in comparison to the burden 
the patient could suffer if their private information was shared without their consent.  It is also 
worth noting that SAMHSA Part 2 is not synonymous with HIPAA.127  Part 2 provides much more 
stringent federal protections than are required under other health privacy laws.128  “This suggests 
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that providers risk non-compliance by relying solely on their HIPAA policies to safeguard Part 2 
Program patients’ privacy.”129  In relation to interoperability, Part 2 seemingly requires informed 
written consent to include this information in a patient’s EHR, which would be possible to 
achieve.130  What is less clear, however, is if the patient must give written consent for each person 
who may access the information.131  Even if a provider does not look at the particular record which 
indicates a patient’s past SUD treatment, the fact that they have access to the information by virtue 
of access to the API would seem to indicate that the patient should be able to dictate whether or 
not they consent to such access.  Although software programming may solve this by requiring 
patient consent on an on-going basis, it is clear that this requirement is in direct conflict with the 
affirmative requirement of the interoperability rule to disclose and make available all patient 
information.  Without a clearer understanding of the specific capabilities and features of the API, 
the importance of patient privacy should trump the affirmative requirement to include the 
information in the EHR.  
There are also a variety of state-specific laws aimed at maintaining the confidentiality of 
and protecting certain types of patient information that requires a heightened level of security. 
These laws regulate, among other things, the use and storage of genetic information, pregnancy 
and other women’s’ health information, and information pertaining to HIV/AIDS diagnoses. 
Genetic information132 and a patient’s ability to control the use and storage of his or her 
genetic information is “at the heart of controlling and protecting an individual’s rights.”133  
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“Genetic Liberty” is defined as the personal control of all aspects of a person’s genetic make-up, 
including genetic material and information.134  There are a variety of laws between and among the 
United States which dictate how genetic tissue may be collected, stored, and used for research and 
disease prevention.135  Most state legislatures have enacted legislation with the purpose and effect 
of safeguarding genetic information at a heightened level than other types of health information.136  
This approach, known as genetic exceptionalism, “calls for special legal protections for genetic 
information as a result of its predictive, personal and familial nature and other unique 
characteristics.”137  Some commentators argue in favor of treating genetic information the same as 
other health information because “genetic information is simply another form of health 
information and is, therefore, difficult to distinguish from other health information, all of which 
deserves equal protection under the law.”138  With respect to privacy, Washington is the only state 
that explicitly complies with this approach by treating genetic information the same as other health 
information.139  It does so simply by including genetic information in the definition of health care 
information under the state health privacy law.140  This means that every piece of information in a 
patient’s medical record is confidential and requires express written consent for disclosure.  While 
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a total of twenty-six states require written consent to disclose genetic information, only seven states 
require written consent to retain that same information.141  Perhaps even more alarming, of the 
twenty-six states that do require consent to disclose genetic information, only five define genetic 
information as personal property—belonging to the person from whom it is extracted.142  The 
inclusion of genetic information in a patient’s EHR poses a problem similar to that presented with 
SUD treatment information—in those states which require specific consent, it is unclear whether 
the API will contain the necessary functions to comply with state-specific privacy laws.  It is 
unclear whether there will be a method by which the API monitors the location from which the 
information is accessed.  Ideally, it will include a mechanism by which the sensitive information 
is secured and only viewable by providers to whom patients have expressly granted access. 
Information regarding HIV/AIDS diagnoses and treatment are typically subject to 
heightened scrutiny and pose similar problems to those discussed in connection with genetic 
information.  Virtually all states have enacted some HIV-specific statutes, many of which concern 
information collection and protection either directly or indirectly.143  “Twenty-three states classify 
HIV/AIDS as a separate category of disease, sixteen classify it as a communicable disease, and 
twelve as a sexually transmitted disease.”144  All states require reporting of AIDS cases to the state 
or local health department, and forty-one states also require reporting of HIV infection.145  Much 
like the limited-scope disclosure allowed by HIPAA, forty-eight states allow for disclosure of 
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HIV-related information in certain proscribed circumstances.146  The most commonly cited 
permissible disclosures relevant to interoperability are to: a health care provider involved in the 
patient’s care (43); blood banks or organ donors (22); epidemiologists and researchers (22); 
HMOs, health care institutions, or mental health facilities (14); and insurance companies (8).147  
Some disclosure provisions require that patient-identifying information be removed from the data, 
which would not be consistent with the goal of interoperability, but would be consistent with 
patient privacy goals.148  “Thirty-eight states report statutory requirements for specific consent for 
HIV testing including consent to the release of information.”149  
Conversely, just because a state lacks an HIV-specific consent statute does not necessarily 
mean that informed consent is not required in a particular state.150  Informed consent may be 
required by other statutes, common law, regulations or policies.151  Consistent with, but reaching 
farther than, the stated objectives of HIPAA, “[f]orty-five states have either criminal or civil 
penalties for unauthorized disclosure of HIV related information.152  Thirty-three states have 
criminal penalties, thirty-three have civil penalties and twenty-one provide for both civil and 
criminal penalties.”153  For providers tasked with updating the health information of their patients 
in order to comply with the interoperability rule, and tasked with safeguarding the privacy of their 
patients’ most sensitive information, there is no clear path forward.  Compliance with both rules 
is seemingly impossible—and providers are forced to face potential civil and/or criminal penalties 
for including a patient’s information in his or her EHR.  This seems antithetical to the stated 
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objectives behind interoperability.  The point of creating the open API is to ease the burden on 
providers, not to force them to choose which laws to break and which to obey.   
VI. The Role of the Internet 
The California Consumer Privacy Act (CCPA) was passed with the intention of “holding 
businesses accountable for data protection through strict guidelines and threatening consequences, 
the new California privacy act is setting the foundation for US data privacy in 2020.”154  For 
patients who reside in California and wish to access their health information via the open API 
structure, the CCPA would seemingly limit how they and their providers access and upload that 
data.  The CCPA “outlines new standards for data collection, new consequences for businesses 
that fail to protect user data, and new rights that California consumers can exercise over their 
data.”155  According to the CCPA, “businesses” that collect “consumer” data are subject to the 
heightened regulations.156  Under the CCPA, a “consumer” is defined simply as a California 
“resident” and a “business” is defined as a “for-profit entity that collects ‘consumer’ data” and has 
either: an annual gross revenue over $25 million; or annually buys, receives, sells or shares the 
personal information of 50,000 or more consumers, households, or devices for commercial 
purposes; or derives fifty percent or more of its annual revenue from selling consumer personal 
information.157  By that definition, every healthcare insurer that provides health insurance to 
50,000 or more California residents is a “business” subject to the heightened regulations.  While 
it is unlikely that a single doctor would satisfy the definition of business, it is possible that a 
hospital group or network of providers could ostensibly meet the two-pronged “business” test.  The 
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CCPA applies to all businesses—regardless of the headquarters of the business, itself.158  This is 
perhaps the most important aspect—because all insurers that collect data must comply with the 
regulations outlined in the CCPA. 
  Personal information under the CCPA means “information that identifies, relates to, 
describes, is reasonably capable of being associated with, or could reasonably be linked, directly 
or indirectly, with a particular consumer or household” and includes other categories such as 
biometric information, IP addresses, and inferences drawn about a consumer related to their 
preferences, predispositions, and psychological trends.159  Importantly, the CCPA includes an 
exemption for protected health information collected by a covered entity or business associate 
that is otherwise subject to HIPAA, but because this is not an “entity-wide exemption” it does 
not entirely eliminate an insurance provider’s obligations under the Act.160  Insurance companies 
must still do their due diligence to identify the categories of consumers for whom they collect 
information and “determining whether they fall under an exemption to the law.”161  Though 
insurance companies will not be “selling” patient data in order to make it accessible in 
accordance with the interoperability rule, it is important that they update contracts with their 
service providers to ensure compliance with the CCPA.162 
The purpose underlying the CCPA is, as the name suggests, to give more rights to 
individuals in furtherance of consumer privacy objectives.  It gives individuals a list of enumerated 
rights, all of which concern the access, transfer, editing, and deletion requests of their data.163  It 
establishes greater consequences for businesses that fail to adequately protect data and shifts 
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accountability for data protection onto businesses that collect and handle user information—both 
of which match up well with the rule’s goals to empower patients and incentivize providers to 
generate more patient-friendly solutions.164  On its face, the CCPA is seemingly perfectly aligned 
with the goals outlined in the interoperability rule.  Upon closer inspection, however, it is tough to 
reconcile some of the other rights the CCPA grants with the Final Rule.  For example, the CCPA 
gives consumers the ability to opt-out of certain data-processing practices.165  Again, insurers and 
providers who fall into the category of “businesses” under the CCPA are faced with almost an 
impossible choice—comply with either the interoperability rule or the CCPA.  According to the 
CCPA text, Californians are now entitled to “know what information is being collected about 
them; to know if their personal information is sold or disclosed, and to whom; to say ‘no’ to the 
sale of personal information; to access their personal information; and to equal service and price, 
even if they exercise their privacy rights.”166  Because the interoperability rule does not squarely 
address the way in which the CCPA interacts with the stated requirements, it is tough to know how 
to proceed. 
For health care providers and insurers, the CCPA means they must comply with more state-
specific laws than simply those of state in which they reside.  If their patients, enrollees, 
beneficiaries, etc. travel to or live in a state with different privacy laws than the provider’s home 
state, it is unclear how the interoperability rule changes the requirements.  Under statutes like the 
CCPA, however, it would appear they need to comply with those requirements as well as their 
home state requirements.  This is possible, albeit difficult.  With proper guidance from CMS, it 
should be possible to simultaneously comply with multiple rules.  Because all of these rules are 
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aimed at increasing patient privacy rights and granting access within the existing framework, 
compliance is possible.  It may take time, but CMS is optimistic that the right API can and will be 
developed and that it will enable interoperability, so that providers may remain focused on giving 
the best healthcare possible to their patients.  This further highlights the aforementioned key role 
that the API plays, despite the fact that it has not yet been established.  
VII. Potential Solutions 
It is important to note that just because patients may be granted “access” to their data—the 
affirmative requirement for providers to disclose such information is not accompanied by 
heightened security or privacy measures.  Patients (aside from those residents in California who 
have a private right of action under the CCPA) still do not have any actionable legal right or remedy 
for the misuse or impermissible disclosure of their health information.  This transitional period 
while developers are creating the open API brings a heightened chance of healthcare data breach.  
Lacking any private right of action under HIPAA, patients are in no position to protect themselves 
from over-zealous providers and insurers who are still acclimating to this new structure.  While 
the benefits of interoperability certainly outweigh the initial burdens associated with 
implementation, it is important to keep in mind that this rule was passed for, and its implementation 
and continued use should be tailored to, individual patients whose health and privacy depend on 
it.  In addition, it is important to note that COVID-19 already has and will continue to increase 
pressure on our healthcare system.  In response to the drastic changes that COVID-19 has caused, 
CMS is considering delaying the implementation of the interoperability rule and will offer 
enforcement leniency for various deadlines within the bill.167 
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Because the main goal of interoperability is to make patient data available, more 
protections are needed to ensure that patient data is not subject to breach or misuse without 
recourse.  As written and enacted, the rule does little to actually equip patients with anything 
other than their data.  It does not have a private right of action, such as the one included in the 
CCPA.  This means that patients whose PHI or other data is subject to a breach have no new 
legal protections.  Advocates for greater patient privacy protection have noted that because of the 
rule, “a lot more data, both covered and not covered by [HIPAA], will be available in the 
wild.”168  “A lot more” is putting it lightly.  Currently, 67.7 million Americans are enrolled in 
Medicare,169 and 70.7 million Americans are enrolled in Medicaid and CHIP.170  As the 
Coronavirus pandemic continues to threaten the health, employment, and finances of millions of 
Americans, these enrollment numbers and sure to rise.171   
The need for increased privacy protections, however, does not stem from an  increase in 
enrollment.  This need stems from the existing privacy landscape and the rule itself.  By enlisting 
the help of vendors to develop the APIs on which patients will eventually access their data, CMS 
has failed to account for the privacy risks this poses for patients at an individual level.  This is 
precisely because the rule “lacks the necessary guardrails to protect consumers from actors such 
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as third-party apps that are not required to meet the same stringent privacy and security 
requirements as hospitals.”172 
 In response to this obvious shortcoming, Congress must amend HIPAA to explicitly 
include these third-party apps as covered entities.  The Trump administration and CMS have 
addressed privacy-related concerns by assuring stakeholders “they will take privacy into 
account,”173 and that “it is taking steps to let payers and patients protect their information.”174  
These steps include asking “third-party application developers to attest to certain privacy 
provisions” and educating “enrollees about sharing health information with third parties.”175  
According to HHS, however, “third-party apps that are developed outside of a HIPAA-covered 
entity are not subject to HIPAA rules even if a breach occurs.”176  Simply asking vendors to 
comply without any potential criminal or civil liability for failing to do so is not 
enough/completely juvenile.  Likewise, educating patients is not enough without equipping them 
with a source of legal recourse in the even that their information is misused.   
Given the purpose of the rule and the enforcement power that CMS holds, it is inapposite 
to place the onus on a patient to know whether or not or for which purpose they should give their 
most sensitive health information to a third-party app.  I do not mean to undercut the ability or 
knowledge of patients—I merely mean that patients should not be forced to choose between 
better access to their health data and the protections afforded by the law.  They should be able to 
have both knowledge and legal protection, and it is up to Congress to make that happen.  If the 
success of this rule and the future of interoperability rely on the APIs and third-party apps, there 
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is no reason why those entities should not be accountable the way that hospitals, providers, 
insurers, and their business associates are.  By this I mean, if they play such a crucial role in 
enabling patient access to data, there should be liability for mishandling that information or 
compromising its confidentiality.   
In addition, Congress should amend HIPAA to clearly include a private right of action.  
This would enable patients who suffer injuries as a result of a data breach by a covered entity to 
be made whole.  A private right of action would further incentivize the entities that handle EHR 
to take extra measures to safeguard patient information.  By placing the burden of compliance of 
payers, providers, and the third-party apps without additionally granting individual rights, patients 
do not have adequate privacy protection.  Though the idea of adding a private right of action under 
HIPAA has garnered a plethora of reactions ranging from full support to condemnation, newer, 
more comprehensive privacy statutes like the CCPA and the GDPR in Europe do include private 
causes of action.  The CCPA has not been enacted long enough to definitively determine whether 
the creation of a private right of action has caused a noticeable increase in cases or significantly 
burdened the courts, as opponents of creating a private cause of action suggest.  Though oft-cited, 
there are practical limitations in place that will limit—if not entirely dispel—the proverbial 
“flooding of the courts” that critics often warn against.   
The most obvious safeguard against this concern has plagued privacy advocates and those 
attempting to bring privacy-based claims for many years: standing requirements.  In order to bring 
a claim for anything, including a proposed private right of action under HIPAA, a plaintiff must 
meet Article III Standing requirements.  To have standing to sue, a plaintiff must have “(1) suffered 
an injury in fact, (2) that is fairly traceable to the challenged conduct of the defendant, and (3) that 
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is likely to be redressed by a favorable judicial decision.”177  Standing requirements have long 
served as a barrier to bringing superficial claims, and in the privacy context in particular, they have 
prevented plaintiffs from bringing claims where they suffered no injury in fact.  The need for a 
private right of action is most obvious particularly where CMS and the Trump administration state 
that they are encouraging app developers to create and implement privacy policies.  While privacy 
policies are a good start, they do not equip patients with sufficient standing for redress suffered as 
a result of a health data breach.178  This is due especially to the fact that data breaches are unlike 
other forms of tangible injury—once the data has been breached, it cannot simply be put back in a 
patient’s file.  Those patients whose information is misused and who suffer as a result of that 
breach deserve the ability to pursue that harm the same way that a person who suffers a tortious 
injury is able to. 
Other critics have pointed to congressional intent (or rather, the lack thereof) as a reason 
not to implement or infer a private right of action.179  While it is true that the statute as written 
does not include any means by which private enforcement may occur, it is also true that when 
Congress enacted HIPAA in 1996 it had no way of knowing what the health data privacy landscape 
would look like almost a quarter of a century later.  When Congress amended HIPAA in 2006 to 
allow HHS enforcement, it similarly could not predict with any certainty what the data privacy 
landscape would evolve into.  The push toward interoperability has occurred much more recently, 
and with this major change comes the need for other changes, namely, more protection and more 
enforcement.  As new data privacy risks emerge, and as legislation changes, Congress now has 
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both the understanding and the opportunity to fill in the gaping holes that this changing landscape 
exposes.  
VIII. Conclusion 
It is possible that the perfect API can be developed to allow compliance with a plethora of 
laws and objectives.  Given the advancement of technology and the incentivization that the rule 
provides, the healthcare industry will inevitably generate solutions to these problems as they arise.    
Although it will be costly to initially implement, the API will eventually lower the costs of 
healthcare by decreasing barriers to accessing the data and by enabling researchers to find cures 
for diseases by better aggregating health data.  
In terms of the lasting impact of the rule on patients, if the data can be prioritized or 
stratified in a way that better predicts a patient’s health outcomes, then it would lead to better, 
more informed diagnoses and hopefully lead to a healthier population.  By involving patients on a 
more consistent basis, they will ask better questions, be more involved in their care, and lessen the 
chance that providers will miss a crucial piece of their care (because patients will be able to remind 
them, or to ask questions, or to know when things have been incorrectly updated to their charts). 
This approach helps foster a better system of checks and balances between the patient, provider, 
and insurer.  When patients, providers, and payers all have access to the same information and can 
be directly involved in (and informed of) what is happening, there are more opportunities to correct 
discrepancies and to catch the crucial information that is needed to make the best decision—both 
for the patients’ physical health and financial benefit.  Mere access to this data is not enough to 
achieve the goals of interoperability—patients must be able to hold providers, payers, and vendors 
accountable for any harm that mishandling of this sensitive information causes. 
 
